申请人:Linder Karen E.
公开号:US20120045393A1
公开(公告)日:2012-02-23
The invention is directed to analogs of LHRH-II and, more generally, to analogs of the LHRH family in which modifications have been made that confer enhanced binding affinity for LHRH receptors and/or improved metabolic stability.
The invention is further directed to methods of targeted therapy and targeted imaging in patients with sex-hormone-related cancers or other LHRH-mediated diseases.
该发明涉及LHRH-II的类似物,更一般地,涉及LHRH家族的类似物,其中进行了改性以赋予LHRH受体更强的结合亲和力和/或改善代谢稳定性。该发明进一步涉及在患有性激素相关癌症或其他LHRH介导疾病的患者中进行有针对性的治疗和有针对性的成像的方法。